Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells

Margarita Pustovalova1, Philipp Malakhov1, Anastasia Guryanova1

  • 1School of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Russia.

Insights

This study explored how non-small cell lung cancer (NSCLC) cells become resistant to radiation therapy. Researchers identified specific gene expression changes that may offer new therapeutic targets for improving NSCLC treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Radioresistance presents a significant challenge in treating non-small cell lung cancer (NSCLC).
  • Understanding the molecular mechanisms underlying NSCLC radioresistance is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the transcriptional alterations in radioresistant NSCLC cells.
  • To identify key genes and molecular pathways associated with radioresistance in NSCLC.
  • To establish radioresistant subclones of NSCLC cell lines for further study.

Main Methods:

  • Establishment of radioresistant subclones from p53 wild-type (A549) and p53-deficient (H1299) NSCLC cell lines.
  • RNA sequencing (RNA-seq) to analyze global gene expression changes.
  • Utilizing the Oncobox bioinformatics platform to quantify pathway activation differences.

Main Results:

  • In p53 wild-type A549 cells, 322 genes were differentially expressed after irradiation.
  • In p53-deficient H1299 cells, 1628 genes and 1616 pathways showed altered expression post-irradiation.
  • Significant transcriptional reprogramming occurs in NSCLC cells upon development of radioresistance.

Conclusions:

  • Gene expression patterns in radioresistant NSCLC cells reflect complex biological processes.
  • Identified genes and pathways may serve as potential biomarkers for NSCLC radioresistance.
  • These findings suggest novel therapeutic targets for overcoming radioresistance in NSCLC treatment.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K